BioLargo (BioLargo) COGS-to-Revenue : 0.52 (As of Dec. 2023)

View and export this data going back to 1991. Start your Free Trial

What is BioLargo COGS-to-Revenue?

BioLargo's Cost of Goods Sold for the three months ended in Dec. 2023 was $2.28 Mil. Its Revenue for the three months ended in Dec. 2023 was $4.37 Mil.

BioLargo's COGS to Revenue for the three months ended in Dec. 2023 was 0.52.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. BioLargo's Gross Margin % for the three months ended in Dec. 2023 was 47.78%.

BioLargo COGS-to-Revenue Historical Data

The historical data trend for BioLargo's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLargo COGS-to-Revenue Chart

BioLargo Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.51

0.50

0.56

0.51

0.50

BioLargo Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.54	0.52	0.43	0.46	0.52

BioLargo COGS-to-Revenue Calculation

BioLargo's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	6.076	/	12.23
	=	0.50

BioLargo's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	2.282	/	4.37
	=	0.52

BioLargo (OTCPK:BLGO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

BioLargo's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	2.282 / 4.37
	=	47.78 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

BioLargo COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioLargo's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLargo (BioLargo) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » BioLargo Inc (OTCPK:BLGO) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

14921 Chestnut Street, Westminster, CA, USA, 92683

Website

https://www.biolargo.com

BioLargo Inc invents, develops, and commercializes platform technologies to solve challenging environmental problems like PFAS contamination, advanced water, and wastewater treatment, industrial odor, and VOC control, air quality control, and infection control. The company holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. BioLargo invents or acquires novel technologies and develops them to maturity through its operating subsidiaries. It monetizes through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation, and/or the sale of the IP. The firm's technologies are commercially available and are advancing as disrupters in their respective markets.

Executives

Linda Park	director	14921 CHESTNUT STREET, WESTMINSTER CA 92683
Christina Elaine Bray	director	PO BOX 234, FREDERICK CO 80530
Jack B. Strommen	director	7108 31ST AVENUE N., MINNEAPOLIS MN 55427
Roberts Kent Charles Ii	director	1146 OXFORD ROAD, SAN MARINO CA 91108
John S. Runyan	director	30001 HILLSIDE TERRACE, SAN JUAN CAPISTRANO CA 92675
Dennis E Marshall	director	3500 W. GARRY AVENUE, SANTA ANA CA 92705
Dennis P Calvert	director, 10 percent owner, officer: Chief Executive Officer	3500 GARRY AVE, SANTA ANA CA 92704
New Millennium Capital Partners, Llc	10 percent owner	16333 PHOEBE AVENUE, LA MIRADA CA 90638
Charles K Dargan	officer: Chief Financial Officer	8055 W. MANCHESTER AVE., SUITE 405, PLAYA DEL REY CA 90293
Joseph L Provenzano	director, officer: Corporate Secretary	3500 W. GARRY AVENUE, SANTA ANA CA 92704
Iowc Technologies, Inc.	10 percent owner	2603 MAIN STREET, SUITE 1155, IRVINE CA 92614
Kenneth Reay Code	10 percent owner	16150 HERON AVENUE, LA MIRADA CA 90638
Gary Adrian Cox	director	3500 W. GARRY AVENUE, SANTA ANA CA 92705
Steven V Harrison	director
Eduardo Ruiz	director, 10 percent owner